News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Comstock and Sierra Springs engaged Newmark to market and develop 2,200 acres in Silver Springs, NV for energy, data centers, and advanced manufacturing.
  • Analysts flag Bunge as a tactical long, citing integration mispricing, with a $135 180-day target and a $100 hard stop.
  • Ducommun unveiled VISION 2032 at Investor Day to accelerate growth through acquisitions and an expanded defense franchise.
  • Amesite won a NurseMagic customer under $1,099/month minimum enterprise pricing for up to 1,000-patient census, preserving roughly 85% gross margins.
  • Descartes launched the Datamyne AI Agent to cut global trade data research and analysis time by up to 90% using 500 million shipment records.

Latest Articles

Goldman Sees June Core CPI Slightly Below Consensus, Flags Policy Relevance

Goldman Sees June Core CPI Slightly Below Consensus, Flags Policy Relevance

Goldman Sachs projects June core consumer price index (CPI) to rise 0.17% month-over-month, a touch below market consensus, while headline CPI is expected to fall 0.11% month-over-month. The firm says the release will be an important input for Federal Reserve policy choices, with nuances across rent, travel, energy and autos shaping its softer core…

Macquarie Points to Hyatt as U.S. Hotel RevPAR Accelerates to 8.7% in June

Macquarie Points to Hyatt as U.S. Hotel RevPAR Accelerates to 8.7% in June

Preliminary data compiled by Macquarie shows U.S. revenue per available room (RevPAR) rose 8.7% in June 2026, driven by a mix of leisure travel and World Cup-related demand. The increase reflected gains in both average daily rate and occupancy, with luxury and upper-upscale hotels outperforming lower chainscales. Macquarie favors Hyatt Hotels based…

Mainframe weakness drags IBM shares as Q2 results miss expectations

Mainframe weakness drags IBM shares as Q2 results miss expectations

IBM reported second-quarter revenue and non-GAAP EPS below analyst consensus, citing softness in its Z mainframe transaction processing and a shift in client capital spending toward servers, storage and memory. Shares fell 14% on the news as the company detailed margin contractions, cash flow generation and pockets of growth in Red Hat and Distribu…

Cisco Has Room To Rerate: Buy On Tilted Odds, Not Blind Faith

Cisco Has Room To Rerate: Buy On Tilted Odds, Not Blind Faith

Cisco's shares have recovered from 2025 lows and are trading in the low $120s, but fundamentals and the AI/data-center driven networking cycle argue there is further upside if the market reassigns a higher multiple. The company's strong ROE, $11.8B in free cash flow, and modest leverage underpin a long trade. We lay out an entry at $119.60, stop at…

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Kura Oncology to Present First Long-Term Follow-Up Data Further Supporting Darlifarnib’s Potential to Enhance VEGFR-Targeted Therapy in Renal Cell Carcinoma at KCRS 2026

Kura Oncology announced that updated results from its FIT-001 Phase 1a study evaluating darlifarnib plus cabozantinib in cabozantinib-naïve advanced clear cell renal cell carcinoma (ccRCC) patients will be presented orally at the 2026 Kidney Cancer Research Summit. These long-term follow-up data continue to support darlifarnib's potential to enhanc…

China Ousts Politburo Member Ma Xingrui in Expanded Anti-Corruption Campaign

China Ousts Politburo Member Ma Xingrui in Expanded Anti-Corruption Campaign

China has expelled Ma Xingrui, a former member of the Politburo and ex-deputy head of the central rural work leading group, from the Communist Party following an investigation that found he facilitated appointments, arranged jobs for associates and allowed family members to profit from his position. The Central Commission for Discipline Inspection …

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Atea Pharmaceuticals Initiates First-in-Human Phase 1 Clinical Trial of AT-587 for the Treatment of Hepatitis E Virus

Atea Pharmaceuticals has initiated a first-in-human Phase 1 clinical trial to evaluate the safety, tolerability, and pharmacokinetics of AT-587, an oral antiviral nucleotide analog targeting Hepatitis E Virus (HEV), which currently has no approved treatments. The trial is a randomized, double-blind, placebo-controlled dose escalation study in healt…

USA Rare Earth Produces Commercial Grade Dysprosium Oxide and Neodymium-Praseodymium Oxide Samples from Recycled Magnet Material at Wheat Ridge Facility

USA Rare Earth Produces Commercial Grade Dysprosium Oxide and Neodymium-Praseodymium Oxide Samples from Recycled Magnet Material at Wheat Ridge Facility

USA Rare Earth announced successful production of commercial-grade dysprosium oxide and neodymium-praseodymium oxide samples from recycled rare earth magnet scrap at its Wheat Ridge, Colorado facility. This milestone positions the company among the few Western producers capable of heavy rare earth separation outside of Asia, enhancing its integrate…

Youxin Technology Announces a US$20 Million Strategic Investment Intent and Cooperation Framework with RiverBit

Youxin Technology Announces a US$20 Million Strategic Investment Intent and Cooperation Framework with RiverBit

Youxin Technology Ltd (Nasdaq: YAAS) announced a non-binding term sheet to invest up to $20 million in RiverBit Holding Limited, a company developing a decentralized perpetual contracts trading platform focused on tokenized U.S. equity perpetuals enabled with AI trading strategies. The investment is milestone-based, contingent on RiverBit reaching …

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Pluri Chairman Alejandro Weinstein’s Cumulative Investment Exceeds $17 Million, Ownership Surpasses 30%

Pluri Inc.'s Chairman Alejandro Weinstein has increased his cumulative investment to over $17 million, now owning more than 30% of the company. This reflects his strong confidence in Pluri's advanced 3D cell expansion platform and the company's strategic shift toward commercial operations focused on longevity, tailored biologics, and regenerative m…

Octave to Report Second Quarter 2026 Financial Results on August 12

Octave to Report Second Quarter 2026 Financial Results on August 12

Octave Intelligence plc will report its second quarter 2026 financial results on August 12, 2026, before the U.S. market opens. The company will also hold a live conference call to discuss the results and business outlook. Octave provides software for mission-critical facilities and infrastructure, aiming to improve asset lifecycle performance and …